Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Correction of Severe Myelofibrosis, Impaired Platelet Functions and Abnormalities in a Patient with Gray Platelet Syndrome Successfully Treated by Stem Cell Transplantation.

Favier R, Roussel X, Audia S, Bordet JC, De Maistre E, Hirsch P, Neuhart A, Bedgedjian I, Gkalea V, Favier M, Daguindau E, Nurden P, Deconinck E.

Platelets. 2019 Sep 10:1-5. doi: 10.1080/09537104.2019.1663809. [Epub ahead of print]

PMID:
31502501
2.

Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra® ): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP).

Susen S, Gruel Y, Godier A, Harroche A, Chambost H, Lasne D, Rauch A, Roullet S, Fontana P, Goudemand J, de Maistre E, Chamouard V, Wibaut B, Albaladejo P, Négrier C.

Haemophilia. 2019 Sep;25(5):731-737. doi: 10.1111/hae.13817. Epub 2019 Jul 11. Review.

PMID:
31294904
3.

Multicentre evaluation of CK Prest® for assaying plasma levels of factor IX fused with albumin (Idelvion® ).

Pouplard C, Galinat H, Ternisien C, Blanc Jouvan F, De Maistre E, Duchemin J, Flaujac C, Hézard N, Grand F, Le Cam-Duchez V, Marlu R, Mourey G, Nedelec F, Pineau-Vincent F, Repesse Y, Stépanian A, Szymezak J, Voisin S, Voyer AL, Jeanpierre E, Lasne D; French Study Group on Laboratory Management of bleeding disorders (BIMHO group).

Haemophilia. 2019 Sep;25(5):e327-e330. doi: 10.1111/hae.13812. Epub 2019 Jul 11. No abstract available.

PMID:
31294887
4.

Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR).

Godier A, Garrigue D, Lasne D, Fontana P, Bonhomme F, Collet JP, de Maistre E, Ickx B, Gruel Y, Mazighi M, Nguyen P, Vincentelli A, Albaladejo P, Lecompte T; French Working Group on Perioperative Haemostasis (GIHP).

Arch Cardiovasc Dis. 2019 Mar;112(3):199-216. doi: 10.1016/j.acvd.2018.10.004. Epub 2019 Jan 6.

PMID:
30621917
5.

Management of antiplatelet therapy for non elective invasive procedures of bleeding complications: proposals from the French working group on perioperative haemostasis (GIHP), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR).

Godier A, Garrigue D, Lasne D, Fontana P, Bonhomme F, Collet JP, de Maistre E, Ickx B, Gruel Y, Mazighi M, Nguyen P, Vincentelli A, Albaladejo P, Lecompte T.

Anaesth Crit Care Pain Med. 2019 Jun;38(3):289-302. doi: 10.1016/j.accpm.2018.10.004. Epub 2018 Oct 23.

6.

Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study.

Aguilar C, Sartori M, D'Angelo A, Kabrhel C, Groce J, de Maistre E, Wasan SM, Kassis J, Lazarchick J, Kaide C, Vera PM, Kline J, Courtney DM, Rubin A, Sharafuddin M, Pernod G; DiET Study Group.

Blood Coagul Fibrinolysis. 2018 Sep;29(6):562-566. doi: 10.1097/MBC.0000000000000750.

7.

Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) - September 2016.

Albaladejo P, Pernod G, Godier A, de Maistre E, Rosencher N, Mas JL, Fontana P, Samama CM, Steib A, Schlumberger S, Marret E, Roullet S, Susen S, Madi-Jebara S, Nguyen P, Schved JF, Bonhomme F, Sié P; members of the French Working Group on Perioperative Haemostasis.

Anaesth Crit Care Pain Med. 2018 Aug;37(4):391-399. doi: 10.1016/j.accpm.2018.04.009. Epub 2018 May 2. Review.

8.

Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage.

Seiffge DJ, Kägi G, Michel P, Fischer U, Béjot Y, Wegener S, Zedde M, Turc G, Cordonnier C, Sandor PS, Rodier G, Zini A, Cappellari M, Schädelin S, Polymeris AA, Werring D, Thilemann S, Maestrini I, Berge E, Traenka C, Vehoff J, De Marchis GM, Kapauer M, Peters N, Sirimarco G, Bonati LH, Arnold M, Lyrer PA, De Maistre E, Luft A, Tsakiris DA, Engelter ST; Novel Oral Anticoagulants in Stroke Patients study group.

Ann Neurol. 2018 Mar;83(3):451-459. doi: 10.1002/ana.25165. Epub 2018 Mar 3.

PMID:
29394504
9.

Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants.

Touzé E, Gruel Y, Gouin-Thibault I, De Maistre E, Susen S, Sie P, Derex L.

Eur J Neurol. 2018 May;25(5):747-e52. doi: 10.1111/ene.13582. Epub 2018 Mar 9.

PMID:
29360254
10.

Position of the French Working Group on Perioperative Haemostasis (GIHP) on viscoelastic tests: What role for which indication in bleeding situations?

Roullet S, de Maistre E, Ickx B, Blais N, Susen S, Faraoni D, Garrigue D, Bonhomme F, Godier A, Lasne D; GIHP.

Anaesth Crit Care Pain Med. 2019 Oct;38(5):539-548. doi: 10.1016/j.accpm.2017.12.014. Epub 2018 Feb 3.

11.

Postauthorization safety study of Clottafact® , a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study.

Négrier C, Ducloy-Bouthors AS, Piriou V, De Maistre E, Stieltjes N, Borel-Derlon A, Colson P, Picard J, Lambert T, Claeyssens S, Boileau S, Bertrand A, André MH, Fourrier F, Ozier Y, Sié P, Gruel Y, Tellier Z.

Vox Sang. 2018 Feb;113(2):120-127. doi: 10.1111/vox.12624. Epub 2017 Dec 13.

PMID:
29238971
12.

Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.

Schiff M, Roda C, Monin ML, Arion A, Barth M, Bednarek N, Bidet M, Bloch C, Boddaert N, Borgel D, Brassier A, Brice A, Bruneel A, Buissonnière R, Chabrol B, Chevalier MC, Cormier-Daire V, De Barace C, De Maistre E, De Saint-Martin A, Dorison N, Drouin-Garraud V, Dupré T, Echenne B, Edery P, Feillet F, Fontan I, Francannet C, Labarthe F, Gitiaux C, Héron D, Hully M, Lamoureux S, Martin-Coignard D, Mignot C, Morin G, Pascreau T, Pincemaille O, Polak M, Roubertie A, Thauvin-Robinet C, Toutain A, Viot G, Vuillaumier-Barrot S, Seta N, De Lonlay P.

J Med Genet. 2017 Dec;54(12):843-851. doi: 10.1136/jmedgenet-2017-104903. Epub 2017 Sep 27. Review.

PMID:
28954837
13.

Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study.

Gouin-Thibault I, Freyburger G, de Maistre E, Susen S, Delavenne X, Golmard JL, Gruel Y, Sié P; GFHT study group on DOAC.

Thromb Res. 2017 Oct;158:126-133. doi: 10.1016/j.thromres.2017.09.001. Epub 2017 Sep 4.

PMID:
28892657
14.

Management of Severe Bleeding in Patients Treated with Direct Oral Anticoagulants: An Observational Registry Analysis.

Albaladejo P, Samama CM, Sié P, Kauffmann S, Mémier V, Suchon P, Viallon A, David JS, Gruel Y, Bellamy L, de Maistre E, Romegoux P, Thoret S, Pernod G, Bosson JL; GIHP-NACO Study Group.

Anesthesiology. 2017 Jul;127(1):111-120. doi: 10.1097/ALN.0000000000001631.

PMID:
28410272
15.

Bleeding risk of surgery and its prevention in patients with inherited platelet disorders.

Orsini S, Noris P, Bury L, Heller PG, Santoro C, Kadir RA, Butta NC, Falcinelli E, Cid AR, Fabris F, Fouassier M, Miyazaki K, Lozano ML, Zúñiga P, Flaujac C, Podda GM, Bermejo N, Favier R, Henskens Y, De Maistre E, De Candia E, Mumford AD, Ozdemir GN, Eker I, Nurden P, Bayart S, Lambert MP, Bussel J, Zieger B, Tosetto A, Melazzini F, Glembotsky AC, Pecci A, Cattaneo M, Schlegel N, Gresele P; European Hematology Association - Scientific Working Group (EHA-SWG) on thrombocytopenias and platelet function disorders.

Haematologica. 2017 Jul;102(7):1192-1203. doi: 10.3324/haematol.2016.160754. Epub 2017 Apr 6.

16.

[Hemorrhage treatment: Evaluation of the proper use of fibrinogen concentrate].

Howlett J, Prudent C, De Maistre E, Fagnoni P, Lazzarotti A.

Therapie. 2017 Oct;72(5):517-524. doi: 10.1016/j.therap.2017.01.009. Epub 2017 Feb 22. French.

PMID:
28336161
17.

Are Myeloproliferative neoplasms a risk factor for Heparin-Induced Thrombocytopenia?

Bovet J, De Maistre E, Bejot Y, Girodon F.

Br J Haematol. 2016 Nov;175(3):537-539. doi: 10.1111/bjh.13874. Epub 2015 Dec 23. No abstract available.

PMID:
26699699
18.

Incremental predictive value of mean platelet volume/platelet count ratio in in-hospital stroke after acute myocardial infarction.

Guenancia C, Hachet O, Stamboul K, Béjot Y, Leclercq T, Garnier F, Yameogo NV, de Maistre E, Cottin Y, Lorgis L.

Platelets. 2017 Jan;28(1):54-59. doi: 10.1080/09537104.2016.1203397. Epub 2016 Jul 26.

PMID:
27459905
19.

Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study.

Pernod G, Wu H, de Maistre E, Lazarchick J, Kassis J, Aguilar C, Vera PM, Palareti G, D'Angelo A; DiET Study Group (Jeffrey Caterino, Fabienne Dutrillaux, Gary Headden, Colin Kaide, Maxime Maignan, Raphaël Marlu, Anais Richard, Cindy Tissier).

Blood Coagul Fibrinolysis. 2017 Apr;28(3):254-260. doi: 10.1097/MBC.0000000000000591.

20.

Lupus anticoagulant-hypoprothrombinemia syndrome and catastrophic antiphospholipid syndrome in a patient with antidomain I antibodies.

Galland J, Mohamed S, Revuz S, de Maistre E, de Laat B, Marie PY, Zuily S, Lévy B, Regnault V, Wahl D.

Blood Coagul Fibrinolysis. 2016 Jul;27(5):580-2. doi: 10.1097/MBC.0000000000000545.

PMID:
27380476
21.

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.

Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P, Poullin P, de Maistre E, Provôt F, Delmas Y, Perez P, Benhamou Y, Stepanian A, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies.

Lancet Haematol. 2016 May;3(5):e237-45. doi: 10.1016/S2352-3026(16)30018-7. Epub 2016 Apr 16.

PMID:
27132698
22.

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial.

Tardy-Poncet B, Nguyen P, Thiranos JC, Morange PE, Biron-Andréani C, Gruel Y, Morel J, Wynckel A, Grunebaum L, Villacorta-Torres J, Grosjean S, de Maistre E.

Crit Care. 2015 Nov 11;19:396. doi: 10.1186/s13054-015-1109-0.

23.

Natural history of patients with congenital dysfibrinogenemia.

Casini A, Blondon M, Lebreton A, Koegel J, Tintillier V, de Maistre E, Gautier P, Biron C, Neerman-Arbez M, de Moerloose P.

Blood. 2015 Jan 15;125(3):553-61. doi: 10.1182/blood-2014-06-582866. Epub 2014 Oct 15.

24.

Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance.

de Maistre E, Volot F, Mourey G, Aho LS, Ternisien C, Briquel ME, Bertrand MA, Tardy B, Frotscher B, Nguyen P, Dumont L, Vandroux D, Hézard N, Trossaërt M.

Thromb Haemost. 2014 Oct;112(4):825-30. doi: 10.1160/TH14-02-0108. Epub 2014 Aug 7.

PMID:
25103956
25.

Spectrum of the mutations in Bernard-Soulier syndrome.

Savoia A, Kunishima S, De Rocco D, Zieger B, Rand ML, Pujol-Moix N, Caliskan U, Tokgoz H, Pecci A, Noris P, Srivastava A, Ward C, Morel-Kopp MC, Alessi MC, Bellucci S, Beurrier P, de Maistre E, Favier R, Hézard N, Hurtaud-Roux MF, Latger-Cannard V, Lavenu-Bombled C, Proulle V, Meunier S, Négrier C, Nurden A, Randrianaivo H, Fabris F, Platokouki H, Rosenberg N, HadjKacem B, Heller PG, Karimi M, Balduini CL, Pastore A, Lanza F.

Hum Mutat. 2014 Sep;35(9):1033-45. doi: 10.1002/humu.22607. Epub 2014 Jul 15. Review.

PMID:
24934643
26.

Unusual Case of HIT With Cardiac Arrest During Hemodialysis.

Grandvuillemin A, Zanetta G, Perrin J, Amiral J, Elalamy I, de Maistre E.

Ann Pharmacother. 2014 Aug;48(8):1086-1089. Epub 2014 May 20.

PMID:
24847160
27.

Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (STic Expert(®) HIT) for the diagnosis of heparin-induced thrombocytopenia.

Leroux D, Hezard N, Lebreton A, Bauters A, Suchon P, de Maistre E, Biron C, Huisse MG, Ternisien C, Voisin S, Gruel Y, Pouplard C.

Br J Haematol. 2014 Sep;166(5):774-82. doi: 10.1111/bjh.12939. Epub 2014 May 12.

PMID:
24815503
28.

Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia.

Noris P, Schlegel N, Klersy C, Heller PG, Civaschi E, Pujol-Moix N, Fabris F, Favier R, Gresele P, Latger-Cannard V, Cuker A, Nurden P, Greinacher A, Cattaneo M, De Candia E, Pecci A, Hurtaud-Roux MF, Glembotsky AC, Muñiz-Diaz E, Randi ML, Trillot N, Bury L, Lecompte T, Marconi C, Savoia A, Balduini CL, Bayart S, Bauters A, Benabdallah-Guedira S, Boehlen F, Borg JY, Bottega R, Bussel J, De Rocco D, de Maistre E, Faleschini M, Falcinelli E, Ferrari S, Ferster A, Fierro T, Fleury D, Fontana P, James C, Lanza F, Le Cam Duchez V, Loffredo G, Magini P, Martin-Coignard D, Menard F, Mercier S, Mezzasoma A, Minuz P, Nichele I, Notarangelo LD, Pippucci T, Podda GM, Pouymayou C, Rigouzzo A, Royer B, Sie P, Siguret V, Trichet C, Tucci A, Saposnik B, Veneri D; European Hematology Association – Scientific Working Group on Thrombocytopenias and Platelet Function Disorders.

Haematologica. 2014 Aug;99(8):1387-94. doi: 10.3324/haematol.2014.105924. Epub 2014 Apr 24.

29.

Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A.

Casini A, De Maistre E, Casini-Stuppi V, Fontana P, Neerman-Arbez M, de Moerloose P.

Blood Coagul Fibrinolysis. 2014 Apr;25(3):280-2. doi: 10.1097/MBC.0000000000000039.

PMID:
24389539
30.

[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013].

Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P.

Ann Fr Anesth Reanim. 2013 Oct;32(10):691-700. doi: 10.1016/j.annfar.2013.04.016. Epub 2013 Aug 30. Review. French. Erratum in: Ann Fr Anesth Reanim. 2014 Mar;33(3):198-9.

PMID:
23993157
31.

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.

Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P; Working Group on Perioperative Haemostasis.

Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):382-93. doi: 10.1016/j.acvd.2013.04.009. Epub 2013 Jun 25.

32.

Successful management of heparin-induced thrombocytopenia using argatroban in a very old woman: a case report.

Putot A, Perrin S, Sordet-Guépet H, de Maistre E, Manckoundia P.

Case Rep Med. 2013;2013:586989. doi: 10.1155/2013/586989. Epub 2013 Mar 5.

33.

Prestroke antiplatelet therapy and early prognosis in stroke patients: the Dijon Stroke Registry.

Béjot Y, Aboa-Eboulé C, de Maistre E, Jacquin A, Troisgros O, Hervieu M, Osseby GV, Rouaud O, Giroud M.

Eur J Neurol. 2013 Jun;20(6):879-90. doi: 10.1111/ene.12060. Epub 2012 Dec 24.

PMID:
23278940
34.

Phylogenetic and functional diversity of Bacteria and Archaea in a unique stratified lagoon, the Clipperton atoll (N Pacific).

Galand PE, Bourrain M, De Maistre E, Catala P, Desdevises Y, Elifantz H, Kirchman DL, Lebaron P.

FEMS Microbiol Ecol. 2012 Jan;79(1):203-17. doi: 10.1111/j.1574-6941.2011.01209.x.

35.

Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies.

Zuily S, Regnault V, Selton-Suty C, Eschwège V, Bruntz JF, Bode-Dotto E, De Maistre E, Dotto P, Perret-Guillaume C, Lecompte T, Wahl D.

Circulation. 2011 Jul 12;124(2):215-24. doi: 10.1161/CIRCULATIONAHA.111.028522. Epub 2011 Jun 20.

PMID:
21690492
36.

Experts' opinion or the serotonin release assay as a gold standard for the diagnosis of heparin-induced thrombocytopenia (HIT)?

Tardy B, Presles E, Akrour M, de Maistre E, Lecompte T, Tardy-Poncet B.

J Thromb Haemost. 2011 Aug;9(8):1667-9. doi: 10.1111/j.1538-7836.2011.04385.x. Review. No abstract available.

37.

De Novo 21q22.1q22.2 deletion including RUNX1 mimicking a congenital infection.

Thevenon J, Callier P, Thauvin-Robinet C, Mejean N, Falcon-Eicher S, Maynadie M, de Maistre E, Bidot S, Huet F, Beri-Dexheimer M, Jonveaux P, Mugneret F, Faivre L.

Am J Med Genet A. 2011 Jan;155A(1):126-9. doi: 10.1002/ajmg.a.33809. No abstract available.

PMID:
21204219
38.

Plasma phospholipid transfer protein deficiency in mice is associated with a reduced thrombotic response to acute intravascular oxidative stress.

Desrumaux C, Deckert V, Lemaire-Ewing S, Mossiat C, Athias A, Vandroux D, Dumont L, Monier S, Pais de Barros JP, Klein A, De Maistre E, Blache D, Beley A, Marie C, Garnier P, Lagrost L.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2452-7. doi: 10.1161/ATVBAHA.110.207654. Epub 2010 Sep 23.

PMID:
20864671
39.

Clinical characteristics and laboratory testing of patients with suspected HIT: a survey on current practice in 11 university hospitals in France.

Bidet A, Tardy Poncet B, Desprez D, de Maistre E, Presles E, Lecompte T, Lavenu-Bombled C, Huisse MG, Wolf M, Morange P, Racadot E, Mouton C, Grunebaum L, Pouplard C, Tardy B; GEHT-HIT study group.

Thromb Res. 2010 Jun;125(6):e294-9. doi: 10.1016/j.thromres.2010.02.003. Epub 2010 Feb 23.

PMID:
20181380
40.

Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myocardial infarction.

Lorgis L, Amoureux S, de Maistre E, Sicard P, Bejot Y, Zeller M, Vergely C, Sequeira-Le Grand A, Lagrost AC, Berchoud J, Cottin Y, Rochette L.

Fundam Clin Pharmacol. 2010 Aug;24(4):525-30. doi: 10.1111/j.1472-8206.2009.00790.x. Epub 2009 Nov 10.

PMID:
19909348
41.

[A case of cutaneous and mucous haemorrhage secondary to vitamin K deficiency in hyperemesis gravidarum].

Devignes J, Grare M, Raft J, Vial F, Hacquard M, Bouaziz H, Lecompte T, de Maistre E.

Ann Fr Anesth Reanim. 2009 Jul-Aug;28(7-8):697-700. doi: 10.1016/j.annfar.2009.05.016. Epub 2009 Jul 9. French.

PMID:
19592197
42.

Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia.

Elalamy I, Tardy-Poncet B, Mulot A, de Maistre E, Pouplard C, Nguyen P, Cleret B, Gruel Y, Lecompte T, Tardy B; GEHT HIT Study Group.

Thromb Res. 2009 Nov;124(5):554-9. doi: 10.1016/j.thromres.2009.04.002. Epub 2009 May 1.

PMID:
19410277
43.

High incidence of venous thrombosis after surgery for abdominal aortic aneurysm.

de Maistre E, Terriat B, Lesne-Padieu AS, Abello N, Bouchot O, Steinmetz EF.

J Vasc Surg. 2009 Mar;49(3):596-601. doi: 10.1016/j.jvs.2008.10.005.

44.

[Discrepancy between two methods of D-dimers measurement: one case of human anti-mouse antibody interference].

Rouvière JA, Devignes J, de Maistre E, Kennel A, Chabot F, Lecompte T.

Ann Biol Clin (Paris). 2008 Jul-Aug;66(4):441-6. doi: 10.1684/abc.2008.0247. French.

45.

[Multiple osteonecroses and venous thrombosis: one case of patient with a novel mutation of protein C (N102S) and heterozygous for FV Leiden].

Benbih M, de Maistre E, Lecompte T, Mainard D, Laprevote MC, Alhenc-Gelas M, Devignes J.

Ann Biol Clin (Paris). 2008 Jul-Aug;66(4):437-40. doi: 10.1684/abc.2008.0234. French.

46.

Activated protein C resistance test using factor VIII-deficient plasma: a new approach to the venous thrombotic risk?

André E, Hacquard M, Alnot Y, de Maistre E, Lecompte T.

Thromb Haemost. 2007 Sep;98(3):693-4. No abstract available.

PMID:
17849066
47.

[Willebrand factor deficiency and septorhinoplasty].

Devignes J, Saviot A, de Maistre E, Briquel ME, Lecompte T, Jankowski R.

Ann Otolaryngol Chir Cervicofac. 2007 Nov;124(5):222-7. French.

PMID:
17692279
48.

Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.

Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot PG, Hachulla E, Harlé JR, Sié P, Boffa MC.

Thromb Haemost. 2007 Jun;97(6):949-54.

PMID:
17549297
49.

Diagnosis and management of heparin-induced thrombocytopenia.

de Maistre E, Gruel Y, Lasne D.

Can J Anaesth. 2006 Jun;53(6 Suppl):S123-34. Review.

PMID:
16766786
50.

Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene.

Picard V, Nowak-Göttl U, Biron-Andreani C, Fouassier M, Frere C, Goualt-Heilman M, de Maistre E, Regina S, Rugeri L, Ternisien C, Trichet C, Vergnes C, Aiach M, Alhenc-Gelas M.

Hum Mutat. 2006 Jun;27(6):600. Erratum in: Hum Mutat. 2006 Nov;27(11):1160.

PMID:
16705712

Supplemental Content

Loading ...
Support Center